Literature DB >> 18071735

Subretinal injection of preservative-free triamcinolone acetonide and supernatant vehicle in rabbits: an electron microscopy study.

Maurício Maia1, Fernando Marcondes Penha, Michel Eid Farah, Eduardo Dib, André Príncipe, Acácio A S Lima Filho, Octaviano Magalhães, Edna Freymüller, Eduardo B Rodrigues.   

Abstract

BACKGROUND: To evaluate the effect of injections of benzyl alcohol (BA)-free triamcinolone acetonide (TA) solution (MTA-PF) and the supernatant vehicle of TA (STA) containing BA into the subretinal space of rabbit eyes.
METHODS: Sixteen rabbits underwent vitrectomy and subretinal injection of 0.02 ml of either 40 mg/ml MTA-PF, 40 mg/ml STA, or balanced salt solution (BSS). The animals were examined 6, 12, and 24 hours and 14 days after the procedure by fundus examination and fluorescein angiography (FA), as well as histological studies by light and transmission electron microscopy. The histological injury was classified in four stages: (1) stage 1, photoreceptor outer segment injury, (2) stage 2, stage 1 + photoreceptor inner segment injury, (3) stage 3, stage 2 + outer nuclear layer damage, and (4) stage 4, stage 3 + retinal pigment epithelium (RPE) damage.
RESULTS: FA showed no window defects in areas where MTA-PF, STA, or BSS have been injected. Histological examination revealed that subretinal BSS-injection resulted in stage 1 damage during entire follow-up. Subretinal injection of MTA-PF resulted in damage stage 2 at 24 h and 14 days after surgery. However, at the STA position, stage 3 damage was noted 24 h and 14 days postoperatively. No RPE or choroidal damage was observed.
CONCLUSIONS: The histological lesions induced by subretinal STA were more relevant than the damage induced by MTA-PF. The vehicle BA may be involved in these abnormalities. The data indicate that care must be taken when using TA during internal limiting membrane peeling in macular hole surgery, due to the possibility of unintentional subretinal migration and for retinal pharmacotherapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18071735     DOI: 10.1007/s00417-007-0718-y

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  38 in total

1.  Potential for patient harm from intrathecal administration of preserved solutions.

Authors:  N J Hetherington; M J Dooley
Journal:  Med J Aust       Date:  2000-08-07       Impact factor: 7.738

2.  Chromovitrectomy: a new field in vitreoretinal surgery.

Authors:  Eduardo B Rodrigues; Carsten H Meyer; Peter Kroll
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2004-12-10       Impact factor: 3.117

3.  Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells.

Authors:  Peter Szurman; Radoslaw Kaczmarek; Martin S Spitzer; Gesine B Jaissle; Patrice Decker; Salvatore Grisanti; Sigrid Henke-Fahle; Sabine Aisenbrey; Karl U Bartz-Schmidt
Journal:  Exp Eye Res       Date:  2006-05-08       Impact factor: 3.467

Review 4.  Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.

Authors:  Jost B Jonas; Ingrid Kreissig; Robert Degenring
Journal:  Prog Retin Eye Res       Date:  2005-03-29       Impact factor: 21.198

5.  Biodegradable scleral implants as new triamcinolone acetonide delivery systems.

Authors:  O Felt-Baeyens; S Eperon; P Mora; D Limal; S Sagodira; P Breton; B Simonazzi; L Bossy-Nobs; Y Guex-Crosier; R Gurny
Journal:  Int J Pharm       Date:  2006-06-02       Impact factor: 5.875

6.  Cell viability effects of triamcinolone acetonide and preservative vehicle formulations.

Authors:  S Shaikh; S Ho; L A Engelmann; S W Klemann
Journal:  Br J Ophthalmol       Date:  2006-02       Impact factor: 4.638

7.  Antibiotics and light responses in superfused bovine retina.

Authors:  P Walter; C Lüke; W Sickel
Journal:  Cell Mol Neurobiol       Date:  1999-02       Impact factor: 5.046

8.  Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.

Authors:  Remzi Avci; Berkant Kaderli
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-21       Impact factor: 3.117

9.  Effects of subretinal injection of patent blue and trypan blue in rabbits.

Authors:  Mauricio Maia; Fernando Penha; Eduardo B Rodrigues; André Príncipe; Eduardo Dib; Carsten H Meyer; Edna Freymuller; Nilva Moraes; Michel Eid Farah
Journal:  Curr Eye Res       Date:  2007-04       Impact factor: 2.424

10.  A simple and rapid method for purification of triamcinolone acetonide suspension for intravitreal injection.

Authors:  Maria C Hernaez-Ortega; Enrique Soto-Pedre
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2004 Jul-Aug
View more
  4 in total

1.  Steroid differentiation: the safety profile of various steroids on retinal cells in vitro and their implications for clinical use (an American Ophthalmological Society thesis).

Authors:  Baruch D Kuppermann; Leandro Cabral Zacharias; M Cristina Kenney
Journal:  Trans Am Ophthalmol Soc       Date:  2014-07

Review 2.  Intravitreal, Subretinal, and Suprachoroidal Injections: Evolution of Microneedles for Drug Delivery.

Authors:  Rachel R Hartman; Uday B Kompella
Journal:  J Ocul Pharmacol Ther       Date:  2017-12-05       Impact factor: 2.671

Review 3.  Visualizing vitreous in vitrectomy by triamcinolone.

Authors:  Taiji Sakamoto; Tatsuro Ishibashi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-06-20       Impact factor: 3.117

4.  Vitreomacular traction syndrome.

Authors:  Juliana Bottós; Javier Elizalde; J Fernando Arevalo; Eduardo B Rodrigues; Maurício Maia
Journal:  J Ophthalmic Vis Res       Date:  2012-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.